Efg Asset Management (Americas) Corp. Vertex Pharmaceuticals Inc Transaction History

Efg Asset Management (Americas) Corp.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 22, 2021	SELL	$181.39 - $202.99 $337,385 - $377,561	-1,860 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$187.49 - $221.1 $52,122 - $61,465	278 Added 17.57%	1,860 $375,000
Q1 2021 Apr 09, 2021	BUY	$207.02 - $241.31 $61,070 - $71,186	295 Added 22.92%	1,582 $340,000
Q4 2020 Feb 05, 2021	BUY	$207.01 - $276.09 $12,420 - $16,565	60 Added 4.89%	1,287 $304,000
Q3 2020 Nov 06, 2020	BUY	$255.65 - $303.1 $313,682 - $371,903	1,227 New	1,227 $334,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Efg Asset Management (Americas) Corp., based on Form 13F filings with the SEC.

Stay updated on Efg Asset Management (Americas) Corp. with notifications on news.